American Heart Journal
Volume 144, Issue 6 , Pages 995-1002 , December 2002

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)

Received 11 January 2002 ,Accepted 25 April 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by Hoffman-LA Roche Ltd.

☆☆ Guest Editor for this manuscript was Richard C. Becker, MD, University of Massachusetts Medical Center, Worcester, Mass.

★ Reprint requests: Eric J. Topol, MD, FACC, Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, F 25, 9500 Euclid Ave, Cleveland, OH 44195.

★★ E-mail: topole@ccf.org

PII: S0002-8703(02)00223-5

doi: 10.1067/mhj.2002.126118

American Heart Journal
Volume 144, Issue 6 , Pages 995-1002 , December 2002

Article Tools

* Image Usage & Resolution